UNSPSC 51432311: Imidapril hydrochloride

This classification denotes an ace inhibitor with the molecular formula C20H27N3O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7NSF9GG1NU, chemically known as 4-imidazolidinecarboxylic acid, 3-((2s)-2-(((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, monohydrochloride, (4s)- but more generally known as imidapril hydrochloride, which bears US NIH Compound Identifier 5485193.

UNSPSC 51432311 Imidapril hydrochloride is a Commodity code representing individual pharmaceutical active ingredients and formulations procured for clinical and emergency medical use by state and local health agencies. State and local governments buy under this code primarily through their fire rescue departments, healthcare commissions, and cooperative purchasing alliances to stock emergency medications and pharmacy benefit programs. The scope of work encompasses supply of specific pharmaceutical line items—measured in units of individual vials or injections—with strict expiration-dating requirements, regulatory compliance certifications (FDA approval, cGMP, Drug Supply Chain Security Act compliance), and safety documentation including Safety Data Sheets compliant with OSHA Hazard Communication Standards. Issuing bodies include city purchasing departments (Tampa Fire Rescue through the City of Tampa's Purchasing Department), state health commissions (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving state and local government facilities across multiple jurisdictions including Oregon and Minnesota).

Recent activity spans Florida, Texas, and the upper Midwest, with the most concrete opportunity coming from the City of Tampa's IFB for Advanced Life Support Medications (Solicitation 26P00188), due April 8, 2026, with an estimated contract value of $40,000.00 and award to the lowest responsive, responsible bidder within 120 days. The solicitation specifies four medication line items (Labetalol HCI, Epinephrine, Adenosine, and Diltiazem vials) for Tampa Fire Rescue, requires nine-month minimum expiration dates at acceptance and delivery within ten calendar days, includes a 5 percent bid discount for Small Local Business Enterprise participation (not to exceed $10,000), and carries a one-year initial term with two optional one-year renewals plus three unilateral 30-day extensions. The Texas Health and Human Services Commission issued an RFI (HHS0017013) on direct-to-manufacturer prescription programs to gather market intelligence before formal RFP issuance, while MMCAP's RFP (S1070000015802, due March 26, 2026) established multistate cooperative contracts for generic pharmaceuticals and OTC products through three authorized wholesalers, effective July 1, 2026, with evaluation weighted 75 percent on price competitiveness and incumbent extensions running through June 30, 2028.